Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS: JUNE ISSUE PUBLISHED
  • JUNE 2021 Issue has been successfully launched on 1 June 2021.

Abstract

GENESIS OF DREADFUL BLACK FUNGUS INFECTION IN COVID 19 PATIENTS BY VIRTUE OF STEROIDAL THERAPY

*Hero Khan Pathan

ABSTRACT

Mucormycosis is a high-morbidity and mortal Angio-invasive fungal infection. Mucormycotic prevalence is about 1.7 out of 1 000 000 habitats a year. Mucormycosis is mostly caused by ketoacidosis (diabetic or other), Iatrogenic immunosuppression, the use of corticosteroids or deferoxamines, catheter and other catheter-contaminated mucocutaneous damage as well as bandage contact. Mucorales penetrate deep tissues by airborne breathing, inoculation or absorption of airborne spores. A high percentage of patients are colonised, but they do not inhibit them. In the sinus (39%), lungs (24%), skin (19%), brain (9%) and gastrointestinal tract (7%), disseminated diseases (6%) and elsewhere, Mucormycosis more often occur (6 percent). In COVID, 19 patients who are reliant on steroidal treatment to recover from SARS CoV-2, unregulated diabetes and/or immunosuppressants, are recognised to be life-threatening infections caused by virulent angio-invasive moulds with a growing frequency. Mucormycosis is very difficult to diagnose and treat. Progress in recognising pathogenesis and early identification will increase chances for successful management and even cure of this debilitating infection and the recent availability of active, not toxic medicines.

Keywords: Mucormycosis, CoVID 19, Anti-fungal drugs, Black fungus, COVID 19 and Mucormycosis.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More